Updated Jan 17
Related News
Sep 28, 2026
AI found a thermostable mRNA vaccine recipe in six rounds—but the evidence is still preclinical
A peer-reviewed MIT study used Bayesian optimization to find solid-state mRNA vaccine formulations that retained full bioactivity after more than two months at 37°C and produced non-inferior immune responses in reported animal experiments.
AI researchmRNA vaccinesbiotechnology
Apr 5, 2026
Anthropic's $400 Million Bet on Coefficient Bio: Will It Reshape Healthcare AI?
Anthropic is making headlines with a $400 million strategic investment in Coefficient Bio, signaling a bold leap into healthcare AI. Despite challenges like the recent Claude Code leak, this partnership aims to integrate Anthropic's AI technology into biotech innovations, underscoring both the ambition and the risks involved. Can this move redefine drug discovery and healthcare applications? Read on to explore the potential and the pitfalls.
AnthropicCoefficient BioHealthcare AI
Mar 31, 2026
OpenAI Propels Isara into the AI Stratosphere with $94 Million Funding Boost!
OpenAI takes a bold step in the AI world by investing in Isara, a San Francisco-based startup founded just nine months ago by two 23-year-old researchers. The company has already raised $94 million, achieving a staggering $650 million valuation. Isara aims to revolutionize industries like finance and biotechnology through its innovative software for coordinating thousands of AI agents. With backing from industry giants like Stanley Druckenmiller and strategic investment from OpenAI, the startup is poised to lead the emerging trend of neolabs and redefine predictive modeling.
OpenAIIsaraAI Agents